StonvexLoading…
StonvexStonvexStonvexCore line items from FSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.18B | $1.86B | $1.72B | $1.43B |
Operating Income | $340.90M | $281.40M | $224.50M | $160.80M |
Net Income | $246.60M | $216.30M | $157.40M | $120.40M |
EPS (Diluted) | $4.01 | $3.50 | $2.56 | $1.97 |
Total Assets | $2.39B | $1.77B | $1.62B | $1.52B |
Total Liabilities | $1.01B | $579.10M | $618.60M | $663.40M |
Cash & Equivalents | $63.70M | $91.10M | $61.00M | $47.50M |
Free Cash Flow OCF − CapEx | $227.10M | $190.70M | $164.10M | $18.80M |
Shares Outstanding | 60.90M | 61.10M | 61.00M | 60.70M |